MACSINE-109 Tablets
Alpha Lipoic Acid 100mg, Benfotiamine 100mg, Calcium Carbonate 500mg, Chromium Picolinate 200mcg, Folic Acid 1.5mg, Inositol 100mg, Methylcobalamin 1500mcg, Pyridoxine HCl 3mg & Vitamin D3 1000 IU
Reference MRP
₹1380.00
Standard Packaging
10 Strips x 1 x 10 Film-Coated Tablets per outer carton (100 Tablets Box / Shipper: 40 Boxes)
MACSINE-109 Tablets deliver targeted, high-potency nutritional pharmacotherapy for peripheral neuropathy and metabolic nerve damage. Featuring 1500mcg active Methylcobalamin alongside 100mg Benfotiamine (fat-soluble vitamin B1) and 100mg Alpha Lipoic Acid, MACSINE-109 promotes rapid remyelination, blocks advanced glycation end-products, and restores intracellular glutathione levels in stressed nerve bundles.
Lic. 12116801000249Request batch Certificate of Analysis (COA), technical dossier, and institutional rate contracts.
Pharmacological Advantages & Clinical Evidence
- 01
Comprehensive 9-in-1 Neuro-Regenerative Matrix targeting multi-factorial neuropathy pathways.
- 02
Methylcobalamin (1500 mcg): Active coenzyme form of B12 that stimulates myelin basic protein synthesis.
- 03
Benfotiamine (100 mg): Fat-soluble thiamine with 5x higher tissue bioavailability, inhibiting harmful hexosamine and PKC pathways.
- 04
Alpha Lipoic Acid (100 mg): Universal lipid- and water-soluble antioxidant restoring endoneurial microvascular blood flow.
- 05
Blister Foil Protection: 10 x 1 x 10 film-coated tablets blister packaging preventing light and moisture degradation.
Clinical Indications
- —Diabetic Peripheral Neuropathy (Pain, Tingling, Burning, Numbness)
- —Alcoholic & Drug-Induced Polyneuropathy
- —Sciatica, Cervical Radiculopathy & Lumbago
- —Post-Herpetic Neuralgia
- —Axonal Demyelination & Microvascular Hypoperfusion
Technical Specifications
- Active Ingredient
- Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Calcium Carbonate, Chromium Picolinate, Folic Acid, Inositol, Pyridoxine HCl, Vitamin D3
- Dosage Form
- Film-Coated Tablet
- Pharmacopoeial Standard
- In-House Validated Monograph
- Formulation Category
- Neurotrophic & Diabetic Microvascular Complex
- Administration
- 1 tablet daily after main meal with water, or as prescribed by a medical practitioner.
- Packaging Format
- 10 Strips x 1 x 10 Film-Coated Tablets per outer carton (100 Tablets Box / Shipper: 40 Boxes)
- Storage & Stability
- Store below 25°C in a dry environment. Protect from moisture and direct light. | Shelf life: 24 Months from manufacturing date
Mechanism of Action
Methylcobalamin promotes transmethylation and synthesis of lecithin, an essential component of the myelin sheath. Benfotiamine activates transketolase, blocking toxic glycolytic metabolites. Alpha Lipoic Acid reduces lipid peroxidation and enhances neurovascular blood perfusion, while Chromium and Inositol modulate cellular insulin sensitivity.
Institutional FAQs
What conditions are treated with MACSINE-109 Tablets?
MACSINE-109 is formulated to treat and alleviate diabetic peripheral neuropathy, nerve burning sensations, numbness, tingling in hands and feet, sciatica, and radicular back pain.
What makes Benfotiamine in MACSINE-109 superior to regular Vitamin B1?
Benfotiamine is lipid-soluble, allowing it to penetrate cell membranes effortlessly and achieve 5 times higher blood concentrations and up to 25 times higher tissue concentrations than standard water-soluble thiamine.
Procurement & Dossier Request for MACSINE-109 Tablets
Submit your hospital tender requirements, rate-contract bids, or Certificate of Analysis (COA) requests. Our regulatory trade desk dispatches validated batch documentation within 24 hours.
Founder & Managing Director
Nilesh Kumar
Direct Sales & Dispatch Line
+91 79877 79819Regulatory Dossiers & RFQ
reditionpharma@gmail.comRegistered Corporate Office
101, 1st Floor, Bhumi Park Society, Punagam Chorasi Bombay Market, Surat, Gujarat 395010, India